Ads
related to: prostate cancer castration resistant treatment options mayo clinic video- Formulary Lookup Tool
View our Formulary Lookup
For a Prostate Cancer Treatment
- Safety & Efficacy Video
Watch A Video To Learn
More About This Treatment Option.
- Find Patient Support
Discover Available Options
To Support Your Patients
- Access Patient Resources
Download Dosing Card &
Support Program Brochure
- Formulary Lookup Tool
Search results
Results from the WOW.Com Content Network
If the cancer has spread beyond the prostate, treatment options change significantly, so most doctors who treat prostate cancer use a variety of nomograms to predict the probability of spread. Treatment by watchful waiting/active surveillance, HIFU, external-beam radiation therapy, brachytherapy, cryosurgery, and surgery are, in general ...
Lutetium (177 Lu) vipivotide tetraxetan, sold under the brand name Pluvicto, is a radiopharmaceutical medication used for the treatment of prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC). [5] [6] Lutetium (177 Lu) vipivotide tetraxetan is a targeted radioligand therapy. [6] [8]
Androgen deprivation therapy (ADT), also called androgen ablation therapy or androgen suppression therapy, is an antihormone therapy whose main use is in treating prostate cancer. Prostate cancer cells usually require androgen hormones, such as testosterone, to grow. ADT reduces the levels of androgen hormones, with drugs or surgery, to prevent ...
“Fatigue is a huge issue for prostate cancer patients, especially post-treatment,” Balneaves says. “Exercise, as much as a person’s able to, does seem to alleviate fatigue.”
Castration-resistant prostate cancer (CRPC) is prostate cancer that progresses despite extremely low testosterone in the body often due to medical castration. [4] Unlike many other types of prostate cancer, CRPC do not need normal testosterone levels, but they still require regular androgen receptors (AR).
Eventually cancer cells can grow resistant to this treatment. This most-advanced stage of the disease, called castration-resistant prostate cancer, is treated with continued hormone therapy alongside the chemotherapy drug docetaxel. Some tumors metastasize (spread) to other areas of the body, particularly the bones and lymph nodes.
Ads
related to: prostate cancer castration resistant treatment options mayo clinic video